181 related articles for article (PubMed ID: 37118735)
21. Pre-vaccine era cervical human papillomavirus infection among screening population of women in west Austria.
Borena W; Grünberger M; Widschwendter A; Kraxner KH; Marth E; Mayr P; Meier J; Ruth N; Guerrero AT; Marth C; Holm-von Laer D
BMC Public Health; 2016 Aug; 16(1):889. PubMed ID: 27565569
[TBL] [Abstract][Full Text] [Related]
22. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women.
Blossom DB; Beigi RH; Farrell JJ; Mackay W; Qadadri B; Brown DR; Rwambuya S; Walker CJ; Kambugu FS; Abdul-Karim FW; Whalen CC; Salata RA
J Med Virol; 2007 Jun; 79(6):758-65. PubMed ID: 17457908
[TBL] [Abstract][Full Text] [Related]
24. Genotype-specific high-risk human papillomavirus infections and risk factors for cervical dysplasia in women with human immunodeficiency virus in Germany: results from a single-center cross-sectional study.
Wagner A; Skof AS; Sehouli J; Richter R; Henrich W; von Weizsäcker K; Siedentopf JP; Chekerov R; Kaufmann AM; Rohr I
Int J Gynecol Cancer; 2022 Jun; 32(6):716-723. PubMed ID: 35354606
[TBL] [Abstract][Full Text] [Related]
25. High-risk human papillomavirus among HIV-infected women with normal cervical cytology: a pilot study in Jos, Nigeria.
Musa J; Taiwo B; Achenbach C; Olugbenga S; Berzins B; Sagay AS; Idoko JA; Kanki PJ; Murphy RL
Arch Gynecol Obstet; 2013 Dec; 288(6):1365-70. PubMed ID: 23700253
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus prevalence and risk factors among HIV-negative and HIV-positive women residing in rural Eastern Cape, South Africa.
Taku O; Businge CB; Mdaka ML; Phohlo K; Basera W; Garcia-Jardon M; Meiring TL; Gyllensten U; Williamson AL; Mbulawa ZZA
Int J Infect Dis; 2020 Jun; 95():176-182. PubMed ID: 32114194
[TBL] [Abstract][Full Text] [Related]
27. The prevalence of high-risk human papillomavirus genotypes and related risk factors among Iranian women.
Hashemnejad M; Mirmajidi R; Rahimzadeh M; Ataei M
J Med Life; 2022 Nov; 15(11):1340-1346. PubMed ID: 36567834
[TBL] [Abstract][Full Text] [Related]
28. High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N'Djamena, Chad.
Mboumba Bouassa RS; Nodjikouambaye ZA; Sadjoli D; Adawaye C; Péré H; Veyer D; Matta M; Robin L; Tonen-Wolyec S; Moussa AM; Koyalta D; Belec L
PLoS One; 2019; 14(6):e0217486. PubMed ID: 31158254
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and correlates of HPV among women attending family-planning clinics in Thailand.
Marks MA; Gupta S; Liaw KL; Tadesse A; Kim E; Phongnarisorn C; Wootipoom V; Yuenyao P; Vipupinyo C; Rugpao S; Sriplienchan S; Gravitt PE; Celentano DD
BMC Infect Dis; 2015 Mar; 15():159. PubMed ID: 25887797
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of anal dysplasia and HPV genotypes in gynecology patients: The ANGY cross-sectional prospective clinical study protocol.
Pache B; Balaya V; Mathis J; Hübner M; Sahli R; Cavassini M; Sempoux C; Mathevet P; Jacot-Guillarmod M
PLoS One; 2022; 17(10):e0276438. PubMed ID: 36269726
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and Risk Factors for High-Risk Human Papillomavirus Infection and Cervical Disorders: Baseline Findings From an Human Papillomavirus Cohort Study.
Saldaña-Rodríguez P; Bahena-Román M; Delgado-Romero K; Madrid-Marina V; Torres-Poveda K
Cancer Control; 2023; 30():10732748231202925. PubMed ID: 37751562
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus prevalence and type distribution among women attending routine gynecological examinations in Saudi Arabia.
AlObaid A; Al-Badawi IA; Al-Kadri H; Gopala K; Kandeil W; Quint W; Al-Aker M; DeAntonio R
BMC Infect Dis; 2014 Dec; 14():643. PubMed ID: 25496614
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of oncogenic human papillomavirus (HPV 16/18) infection, cervical lesions and its associated factors among women aged 21-49 years in Amhara region, Northern Ethiopia.
Temesgen MM; Alemu T; Shiferaw B; Legesse S; Zeru T; Haile M; Gelanew T
PLoS One; 2021; 16(3):e0248949. PubMed ID: 33760866
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and type-specific distribution of human papillomavirus infection among women in mid-western rural, Nepal- A population-based study.
Thapa N; Maharjan M; Shrestha G; Maharjan N; Petrini MA; Zuo N; He C; Yang J; Xu M; Ge C; Song Z; Cai H
BMC Infect Dis; 2018 Jul; 18(1):338. PubMed ID: 30029626
[TBL] [Abstract][Full Text] [Related]
35. Spectrum of genital human papillomavirus infection in a female adolescent population.
Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
[TBL] [Abstract][Full Text] [Related]
36. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women.
La Ruche G; You B; Mensah-Ado I; Bergeron C; Montcho C; Ramon R; Touré-Coulibaly K; Welffens-Ekra C; Dabis F; Orth G
Int J Cancer; 1998 May; 76(4):480-6. PubMed ID: 9590121
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and distribution of human papillomavirus genotypes among women attending gynecology clinics in northern Henan Province of China.
Wang X; Song Y; Wei X; Wang G; Sun R; Wang M; Zhao L
Virol J; 2022 Jan; 19(1):6. PubMed ID: 34991648
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women.
Obiri-Yeboah D; Akakpo PK; Mutocheluh M; Adjei-Danso E; Allornuvor G; Amoako-Sakyi D; Adu-Sarkodie Y; Mayaud P
BMC Cancer; 2017 Oct; 17(1):688. PubMed ID: 29037188
[TBL] [Abstract][Full Text] [Related]
40. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
